Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

价值:对结果的分析.

André J Scheen

    Lancet (London, England)
    |September 15, 2004
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    Cagrilintide-semaglutide: a new option for patients with type 2 diabetes.

    The lancet. Diabetes & endocrinology·2026
    Same author

    Challenges in mitigating weight regain with incretin-based therapy.

    Lancet (London, England)·2026
    Same author

    Safety of SGLT2 inhibitors for patients with type 2 diabetes: where are we now?

    Expert opinion on drug safety·2026
    Same author

    GLP-1-derived therapies and risk of sarcopenia: myth or reality?

    Expert opinion on drug safety·2026
    Same author

    GLP-1-derived therapies and sarcopenia: plea for a specific focus on at risk special populations.

    Diabetes & metabolism·2025
    Same author

    Ecnoglutide, a biased GLP-1 receptor agonist as a potential new player for type 2 diabetes management?

    The lancet. Diabetes & endocrinology·2025